OVER the next 25 years, Tanzania plans to gradually reduce the dependence of public entities on government subsidies, in what ...
Five issued U.S. patents cover the combination of ImmunityBio’s IL-15 receptor agonist (NAI) with Bacillus Calmette-Guérin ...
Aboard Air Force One (AFP) | 15/05/2026 - 13:11:51 | Trump says Xi 'feels strongly' Iran can't have nuclear weapon ...
Long-term optical imaging studies track bone marrow clearance and extramedullary escape during BCMA CAR-NK therapy.
By Napoleon KofieEvery morning at 5 AM, Maame Esi sets up her table at Makola Market. She sells fabric: Ghanaian prints, ...
ImmunityBio, Inc. , a commercial-stage immunotherapy company, today announced an exclusive U.S. Development and Supply Agreement with Japan BCG Laboratory ("JBL"), the Tokyo-based developer and ...
The UK Treasury has announced plans to revise its ring‑fencing regulations that separate large banks’ core and non‑core ...
Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) ...
Artificial intelligence shows promise for improving care for peripheral artery disease through earlier detection, improved ...
UIUC and Stanford's RecursiveMAS lets AI agents collaborate in embedding space instead of text, cutting token usage by 75% ...
Supplemental BLA seeks to expand the ANKTIVA label to include patients with BCG-unresponsive NMIBC with papillary diseaseFDA ...
Engineered nanoparticles can improve cancer immunotherapy by delivering drugs, antigens, and genetic payloads with greater ...